title: Dorsolateral midbrain MRI abnormalities and ocular motor deficits following cytarabine-based chemotherapy for acute myelogenous leukemia.
authors.affiliation: Department of Ophthalmology, Stanford University School of Medicine, Stanford, California 94304-5353, USA.
authors.forename: Thuy
authors.initials: T
authors.lastname: Doan
authors.forename: Norman
authors.initials: N
authors.lastname: Lacayo
authors.forename: Paul G
authors.initials: PG
authors.lastname: Fisher
authors.forename: Yaping Joyce
authors.initials: YJ
authors.lastname: Liao
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D002648:Child; D003561:Cytarabine / Q000009:adverse effects*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000473:pathology*; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D008636:Mesencephalon / Q000187:drug effects* / Q000473:pathology; D015835:Ocular Motility Disorders / Q000139:chemically induced* / Q000175:diagnosis / Q000473:pathology*; D013995:Time
chemical_list: D000964:Antimetabolites, Antineoplastic; D003561:Cytarabine